Subscribe
Facebook Twitter Instagram Youtube

Hepatitis Australia

Email

carrie@hepatitisaustralia.com

Phone

T: +61 2 62324257

Web

www.hepatitisaustralia.com

Address

PO Box 716, Woden, Canberra ACT ACT 2606 Australia
About Hepatitis Australia

Our Vision

A world without viral hepatitis.

Our Mission

Through national leadership, advocacy, and strong partnerships ensure effective action on hepatitis B and hepatitis C to meet the needs of all Australians.

The way we work

  • We are guided by, and responsive to the needs and interests of all people affected by hepatitis B and hepatitis C.
  • We apply health promotion principles and evidence-based practice to our work.
  • We respect the cultures, traditions, views, and ways of life of Aboriginal and Torres Strait Islander peoples.
  • We value cultural diversity and equality.
  • We collaborate with people and organisations that share our goals.
  • We are ethical, accountable and professional in our work.
  • We are capable and committed, and take bold steps to make real gains.

Our Purpose

Hepatitis Australia helps you by providing national leadership and advocacy on viral hepatitis and support partnerships. The outcomes expected from this are:

  • to decrease new infections of viral hepatitis
  • to increase the community understanding of viral hepatitis
  • to eliminate the barriers to treatment 
  • to provide accessible quality services 
  • to provide support networks
  • to eradicate stigma and discrimination

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)
Confirm consent(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close